{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:23:37Z","timestamp":1783949017310,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Project of National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81500644"],"award-info":[{"award-number":["81500644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hebei province medical applicable technology tracking project","award":["G2019012"],"award-info":[{"award-number":["G2019012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11255-020-02568-x","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T20:02:31Z","timestamp":1594670551000},"page":"2145-2152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-8208","authenticated-orcid":false,"given":"Baoxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-1071","authenticated-orcid":false,"given":"Yunliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"2568_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11255-020-02434-w","volume":"52","author":"ZS Hayder","year":"2020","unstructured":"Hayder ZS, Kareem ZS (2020) Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin. Int Urol Nephrol 52:749\u2013756. https:\/\/doi.org\/10.1007\/s11255-020-02434-w","journal-title":"Int Urol Nephrol"},{"key":"2568_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.archoralbio.2019.05.020","volume":"104","author":"S Techatanawat","year":"2019","unstructured":"Techatanawat S, Surarit R, Chairatvit K, Roytrakul S, Khovidhunkit W, Thanakun S, Izumi Y, Khovidhunkit SP (2019) Salivary and serum cystatin SA levels in patients with type 2 diabetes mellitus or diabetic nephropathy. Arch Oral Biol 104:67\u201375. https:\/\/doi.org\/10.1016\/j.archoralbio.2019.05.020","journal-title":"Arch Oral Biol"},{"issue":"5","key":"2568_CR3","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.kint.2017.04.018","volume":"92","author":"J Galsgaard","year":"2017","unstructured":"Galsgaard J, Persson F, Hansen TW, Jorsal A, Tarnow L, Parving HH, Rossing P (2017) Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy. Kidney Int 92(5):1242\u20131248. https:\/\/doi.org\/10.1016\/j.kint.2017.04.018","journal-title":"Kidney Int"},{"key":"2568_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cbi.2019.05.013","volume":"308","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Chen L, Fan Y, Yan P, Li S, Zhou X (2019) The effect of boletus polysaccharides on diabetic hepatopathy in rats. Chem Biol Interact 308:61\u201369. https:\/\/doi.org\/10.1016\/j.cbi.2019.05.013","journal-title":"Chem Biol Interact"},{"key":"2568_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20143393","volume":"20","author":"K Matoba","year":"2019","unstructured":"Matoba K, Takeda Y, Nagai Y, Kawanami D, Utsunomiya K, Nishimura R (2019) Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease. Int J Mol Sci 20:1\u201315. https:\/\/doi.org\/10.3390\/ijms20143393","journal-title":"Int J Mol Sci"},{"key":"2568_CR6","doi-asserted-by":"publisher","unstructured":"Zhu H, Yu W, Xie Y, Zhang H, Bi Y, Zhu D (2017) Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy. Med Sci Monit 23: 428\u2013436. https:\/\/doi.org\/10.12659\/msm.902783","DOI":"10.12659\/msm.902783"},{"key":"2568_CR7","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/ptr.6430","volume":"33","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yu C, Ji K, Wang X, Li X, Xie H, Wang Y, Huang Y, Qi D, Fan H (2019) Quercetin reduces TNF-\u03b1-induced mesangial cell proliferation and inhibits PTX3 production: involvement of NF-\u03baB signaling pathway. Phytother Res 33:2401\u20132408. https:\/\/doi.org\/10.1002\/ptr.6430","journal-title":"Phytother Res"},{"key":"2568_CR8","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1038\/s41388-019-0848-9","volume":"38","author":"M Rathore","year":"2019","unstructured":"Rathore M, Girard C, Ohanna M, Tichet M, Ben Jouira R, Garcia E, Larbret F, Gesson M, Audebert S, Lacour JP, Montaudi\u00e9 H, Prod'Homme V, Tartare-Deckert S, Deckert M (2019) Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)\/NF-\u03baB signaling pathway. Oncogene 38:5873\u20135889. https:\/\/doi.org\/10.1038\/s41388-019-0848-9","journal-title":"Oncogene"},{"key":"2568_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.lfs.2019.117045","volume":"239","author":"HY Bako","year":"2019","unstructured":"Bako HY, Ibrahim MA, Isah MS, Ibrahim S (2019) Inhibition of JAK-STAT and NF-\u03baB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes. Life Sci 239:117\u2013125. https:\/\/doi.org\/10.1016\/j.lfs.2019.117045","journal-title":"Life Sci"},{"key":"2568_CR10","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1248\/bpb.b19-00526","volume":"42","author":"M Maekawa","year":"2019","unstructured":"Maekawa M, Tadaki H, Tomimoto D, Okuma C, Sano R, Ishii Y, Katsuda Y, Yoshiuchi H, Kakefuda R, Ohta T, Sasase T (2019) A Novel TNF-\u03b1 converting enzyme (TACE) selective inhibitor JTP-96193 prevents insulin resistance in KK-Ay type 2 diabetic mice and diabetic peripheral neuropathy in type 1 diabetic mice. Biol Pharm Bull 42:1906\u20131912. https:\/\/doi.org\/10.1248\/bpb.b19-00526","journal-title":"Biol Pharm Bull"},{"key":"2568_CR11","first-page":"245","volume":"19","author":"R Akc\u0131lar","year":"2016","unstructured":"Akc\u0131lar R, Emel Ko\u00e7ak F, \u015eim\u015fek H, Akc\u0131lar A, Bayat Z, Ece E, K\u00f6kda\u015fgil H (2016) The effect of adropin on lipid and glucose metabolism in rats with hyperlipidemia. Iran J Basic Med Sci 19:245\u2013251","journal-title":"Iran J Basic Med Sci"},{"key":"2568_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1515\/jpem-2019-0329","volume":"33","author":"X Yuan","year":"2020","unstructured":"Yuan X, Chen R, Ouyang Q, Lin X, Ai Z, Zhang Y, Yang X (2020) Novel associations of serum adropin and lipopolysaccharide-binding protein versus lipid profiles in childhood obesity. J Pediatr Endocrinol Metab 33:265\u2013270. https:\/\/doi.org\/10.1515\/jpem-2019-0329","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2568_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11255-019-02348-2","volume":"52","author":"H Xie","year":"2020","unstructured":"Xie H, Li C, Wen Y, Ye W, Cai J, Li H, Li X, Li X (2020) Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy. Int Urol Nephrol 52(2):337\u2013342. https:\/\/doi.org\/10.1007\/s11255-019-02348-2","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"2568_CR14","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s11255-019-02201-6","volume":"51","author":"K Siddiqui","year":"2019","unstructured":"Siddiqui K, Joy SS, Al-Rubeaan K (2019) Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients. Int Urol Nephrol 51(8):1379\u20131386. https:\/\/doi.org\/10.1007\/s11255-019-02201-6","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2568_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10157-019-01797-4","volume":"24","author":"Y Yamaguchi","year":"2020","unstructured":"Yamaguchi Y, Itabashi M, Yumura W, Takei T (2020) Geriatric assessment of estimated glomerular filtration rate: a cross-sectional study. Clin Exp Nephrol 24(3):216\u2013224. https:\/\/doi.org\/10.1007\/s10157-019-01797-4","journal-title":"Clin Exp Nephrol"},{"key":"2568_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12433-w","volume":"10","author":"Y Zhong","year":"2019","unstructured":"Zhong Y, Lee K, Deng Y, Ma Y, Chen Y, Li X, Wei C, Yang S, Wang T, Wong NJ, Muwonge AN, Azeloglu EU, Zhang W, Das B, He JC, Liu R (2019) Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes. Nat Commun 10:1\u201315. https:\/\/doi.org\/10.1038\/s41467-019-12433-w","journal-title":"Nat Commun"},{"key":"2568_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jdiacomp.2019.107479","volume":"34","author":"O Milas","year":"2019","unstructured":"Milas O, Gadalean F, Vlad A et al (2019) Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients. J Diabetes Complications 34:107\u2013114. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107479","journal-title":"J Diabetes Complications"},{"key":"2568_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjdrc-2019-000817","volume":"7","author":"XQ Li","year":"2019","unstructured":"Li XQ, Chang DY, Chen M, Zhao MH (2019) Deficiency of C3a receptor attenuates the development of diabetic nephropathy. BMJ Open Diabetes Res Care 7:1\u20139. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000817","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2568_CR19","doi-asserted-by":"publisher","unstructured":"Xiao H, Sun X, Liu R, Chen Z, Lin Z, Yang Y, Zhang M, Liu P, Quan S, Huang H (2019) Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy. Pharmacol Res 151:104559. https:\/\/doi.org\/10.1016\/j.phrs.2019.104559","DOI":"10.1016\/j.phrs.2019.104559"},{"key":"2568_CR20","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1038\/emm.2015.37","volume":"47","author":"L Qiu","year":"2015","unstructured":"Qiu L, Xu R, Wang S, Li S, Sheng H, Wu J, Qu Y (2015) Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK\/IkB\/NF-kB, in atherosclerotic cell model. Exp Mol Med 47:e171. https:\/\/doi.org\/10.1038\/emm.2015.37","journal-title":"Exp Mol Med"},{"key":"2568_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000368778","volume":"165","author":"S Jaillon","year":"2014","unstructured":"Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, Mantovani A (2014) The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol 165:165\u2013178. https:\/\/doi.org\/10.1159\/000368778","journal-title":"Int Arch Allergy Immunol"},{"issue":"14","key":"2568_CR22","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2147\/TCRM.S162086","volume":"28","author":"C Bala","year":"2018","unstructured":"Bala C, Rusu A, Ciobanu DM, Craciun AE, Roman G (2018) The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine, and insulin dose in patients with insulin-treated type 2 diabetes mellitus. Ther Clin Risk Manag 28(14):955\u2013963. https:\/\/doi.org\/10.2147\/TCRM.S162086","journal-title":"Ther Clin Risk Manag"},{"key":"2568_CR23","doi-asserted-by":"publisher","first-page":"e2520","DOI":"10.1097\/MD.0000000000002520","volume":"95","author":"Y Pang","year":"2016","unstructured":"Pang Y, Tan Y, Li Y, Zhang J, Guo Y, Guo Z, Zhang C, Yu F, Zhao MH (2016) Pentraxin 3 is closely associated with tubulointerstitial injury in lupus nephritis: a large multicenter cross-sectional study. Medicine (Baltimore) 95:e2520. https:\/\/doi.org\/10.1097\/MD.0000000000002520","journal-title":"Medicine (Baltimore)"},{"key":"2568_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1159\/000453159","volume":"40","author":"TW Hung","year":"2016","unstructured":"Hung TW, Tsai JP, Lin SH, Lee CH, Hsieh YH, Chang HR (2016) Pentraxin 3 activates JNK signaling and regulates the epithelial-to-mesenchymal transition in renal ribrosis. Cell Physiol Biochem 40:1029\u20131038. https:\/\/doi.org\/10.1159\/000453159","journal-title":"Cell Physiol Biochem"},{"key":"2568_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0196526","volume":"13","author":"Y Takashi","year":"2018","unstructured":"Takashi Y, Koga M, Matsuzawa Y, Saito J, Omura M, Nishikawa T (2018) Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration. PLoS ONE 13:1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0196526","journal-title":"PLoS ONE"},{"key":"2568_CR26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/0886022X.2016.1209031","volume":"38","author":"S Uzun","year":"2016","unstructured":"Uzun S, Ozari M, Gursu M, Karadag S, Behlul A, Sari S, Koldas M, Demir S, Karaali Z, Ozturk S (2016) Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3. Ren Fai 38:1193\u20131198. https:\/\/doi.org\/10.1080\/0886022X.2016.1209031","journal-title":"Ren Fai"},{"issue":"2018","key":"2568_CR27","doi-asserted-by":"publisher","first-page":"8968573","DOI":"10.1155\/2018\/8968573","volume":"13","author":"X Chen","year":"2018","unstructured":"Chen X, Luo J, Wu M, Pan Z, Xie Y, Wang H, Chen B, Zhu H (2018) Study on association of pentraxin 3 and diabetic nephropathy in a rat model. J Diabetes Res 13(2018):8968573. https:\/\/doi.org\/10.1155\/2018\/8968573","journal-title":"J Diabetes Res"},{"issue":"5","key":"2568_CR28","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s10753-014-9921-2","volume":"37","author":"Y Xiao","year":"2014","unstructured":"Xiao Y, Yang N, Zhang Q, Wang Y, Yang S, Liu Z (2014) Pentraxin 3 inhibits acute renal injury-induced interstitial fibrosis through suppression of IL-6\/Stat3 pathway. Inflammation 37(5):1895\u20131901. https:\/\/doi.org\/10.1007\/s10753-014-9921-2","journal-title":"Inflammation"},{"key":"2568_CR29","doi-asserted-by":"publisher","unstructured":"Maciorkowska M, Musia\u0142owska D, Ma\u0142yszko J (2019) Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease. Adv Clin Exp Med 28:1571\u20131575. https:\/\/doi.org\/10.17219\/acem\/104551","DOI":"10.17219\/acem\/104551"},{"key":"2568_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5173\/ceju.2019.1666","volume":"72","author":"HT Celik","year":"2019","unstructured":"Celik HT, Bilen M, Kazanc\u0131 F, Yildirim ME, \u0130ncebay \u0130B, Erdamar H (2019) Serum adropin as a predictive biomarker of erectile dysfunction in coronary artery disease patients. Cent Euro J Uro 72:302\u2013306. https:\/\/doi.org\/10.5173\/ceju.2019.1666","journal-title":"Cent Euro J Uro"},{"key":"2568_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4149\/bll_2016_020","volume":"117","author":"R Akcilar","year":"2016","unstructured":"Akcilar R, Kocak FE, Simsek H, Akcilar A, Bayat Z, Ece E, Kokdasgil H (2016) Antidiabetic and hypolipidemic effects of adropin in streoptozotocin-induced type 2 diabetic rats. Bratisl Lek Listy 117:100\u2013105. https:\/\/doi.org\/10.4149\/bll_2016_020","journal-title":"Bratisl Lek Listy"},{"key":"2568_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/0004563218820359","volume":"56","author":"S Li","year":"2019","unstructured":"Li S, Sun J, Hu W, Liu Y, Lin D, Duan H, Liu F (2019) The association of serum and vitreous adropin concentrations with diabetic retinopathy. Ann Clin Biochem 56:253\u2013258. https:\/\/doi.org\/10.1177\/0004563218820359","journal-title":"Ann Clin Biochem"},{"key":"2568_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.yjmcc.2019.02.012","volume":"129","author":"D Thapa","year":"2019","unstructured":"Thapa D, Xie B, Zhang M et al (2019) Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice. J Mol Cell Cardiol 129:174\u2013178. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.02.012","journal-title":"J Mol Cell Cardiol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02568-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:03:08Z","timestamp":1626134588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2568"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02568-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (Ethics Committee of Baoding NO.1 Central Hospital approval number #2017010) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}